We are no longer accepting new cases.

PFOA has been linked to several potentially serious illnesses, including cancer. The PFOA contamination of Hoosick Falls’ water supply elevates the risk of these health problems because it far exceeds levels deemed safe by the U.S. Environmental Protection Agency (EPA) and New York State health officials.

Hoosick Falls is a village of approximately 3,500 people in central upstate New York. The surrounding area was once home to a number of manufacturing plants, a few of which still remain.

Some of those facilities utilized PFOA in their manufacturing processes. A synthetic acid and surfactant, PFOA is used in no-stick pots and pans, dental floss, floor wax and strippers, and treatments to make clothing and upholstery resistant to spills and stains.  These companies discharged waste containing PFOA into the environment.

The PFOA contamination problem could date back many decades. While the duration and scope of the contamination remains subject to investigation, the residents of Hoosick Falls had no knowledge of the contamination until very recently.  Indeed, when local efforts first revealed the water contamination, local officials dismissed or otherwise played down the potential risks and dangers.

Now, residents of Hoosick Falls are developing significant illnesses at an unusual and alarming rate. These illnesses are taking a toll on the people of Hoosick Falls.

Hoosick Falls residents are more frequently calling in too sick to go to work. Their children are more often missing school due to illness. Young and old alike are making more trips to doctors’ offices and treatment centers.

Property values are also in decline. The plant where PFOA was used has been declared a State Superfund site. This designation drives away prospective homebuyers. Further, individuals cannot refinance their homes because banks are unwilling to loan money on an asset with diminished value.  Residents who wanted to sell their homes in the near future now feel stuck.

Case updates have been added

Read Class Certification Documents

Health Complications from PFOA in Hoosick Falls Water

Medical research published in peer-reviewed journals has linked PFOA with several serious health conditions. These include:

  • Testicular cancer
  • Kidney cancer
  • Thyroid disease
  • High cholesterol
  • Ulcerative colitis
  • Pregnancy-induced hypertension

The amount of exposure to PFOA necessary to induce health problems is very small. One-half of one part-per-billion is enough to create a risk of injury in humans. That concentration is the equivalent of half a single drop of water placed in an Olympic-sized swimming pool.

The problem of PFOA contamination is compounded by the fact that PFOA does not dissipate once it finds its way into the environment – or finds its way inside a person.

Hoosick Falls PFOA Water Contamination Lawsuit

Weitz & Luxenberg has filed a lawsuit against Saint-Gobain Performance Plastics and Honeywell International, claiming that the companies are the sources of the Hoosick Falls PFOA contamination.

The lawsuits will demand that the defendant companies restore W&L’s clients from Hoosick Falls and environs to their rightful position – the position they would be in but for the harm done to them by PFOA contamination. Learn more about the class action lawsuit filed, In Hoosick Falls, W&L Files Federal Class-Action Lawsuit Against Saint-Gobain and Honeywell.

The class action also seeks the establishment of a medical monitoring program that will protect the health of property owners and help insure an early detection of those ailments linked with exposure to PFOA. 

On May 18, 2020, the Second Circuit Court of Appeals ruled in Plaintiffs’ favor on an appeal by the Defendants seeking to dismiss the class action case. The appellate court ruled that Plaintiffs may pursue claims for medical monitoring, property damage, and nuisance related to Defendants’ contamination of the community with PFOA. The court issued two decisions that explained its ruling: Baker v. Saint-Gobain and Benoit v. Saint-Gobain.

On July 22, 2021, a proposed $65.25 million settlement was announced. This settlement compensates Hoosick Falls residents for their exposure to PFOA. Three defendants agreed to the proposed class settlement: Saint-Gobain Performance Plastics Corp., 3M Co., and Honeywell International Inc. One defendant, E.I. DuPont de Nemours & Co., has not agreed to the settlement.

W&L is laying the groundwork for plaintiffs to seek compensation for:

  • Payment of medical bills
  • Wages lost because of illness brought about by exposure to PFOA-contaminated water
  • Reduced value of real property
  • Pain and suffering
  • Ongoing health monitoring

How Weitz & Luxenberg Can Help

As a nationally recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases.  For more than 25 years, we have dedicated ourselves to holding irresponsible practitioners accountable, and we have won $17 billion for our clients.

Class Certification Documents

001 Notice of Motion for Class Certification

002 Memorandum in Support of Motion for Class Certification

003 Declaration of Stephen G. Schwarz in Support of Class Certification

004 Schwarz Ex. 1 (Jan 2016 Letter from Sen. Chuck Schumer)

005 Schwarz Ex. 2 (July 2016 Letter from AM John McDonald III

006 Schwarz Ex. 3 (December 2015 EPA Statement on PFOA in Hoosick Falls)

007 Schwarz Ex. 4 (2nd Circuit Order Denying Rule 23(f) Petition)

008 Schwarz Ex. 5 (Sullivan v. Saint-Gobain Daubert Decision)

009 Schwarz Ex. 6 (Burdick v. Tonoga Decision and Order on Frye Motions)

010 Schwarz Ex. 7 (3M TSCA 8(e) Letter to EPA, Sept. 2007)

011 Schwarz Ex. 8 (DuPont Information Bulletin X-50f)

012 Schwarz Ex. 9 (Selected Pages from D. Hassel Deposition)

013 Schwarz Ex. 10 (DuPont Responses to First Interrogatories)

014 Schwarz Ex. 11 (DuPont R. Zipfel Email re Biofate Study)

015 Schwarz Ex. 12 (Selected Pages from B. Karrh (DuPont) Deposition)

016 Schwarz Ex. 13 (3M Chronology of Fluorochemicals in Blood)

017 Schwarz Ex. 14 (DuPont Status Review Fluorochemicals in Blood, May 1979)

018 Schwarz Ex. 15 (3M Meeting Minutes with Hodge, August 23 1978)

019 Schwarz Ex. 16 (Broad Aspects – Metabolic Studies in Perspective)

020 Schwarz Ex. 17 (3M Meeting Minutes with Hodge, April 26 1979)

021 Schwarz Ex. 18 (3M Ninety Day Subacute Rhesus Monkey Toxicity Study)

022 Schwarz Ex. 19 (3M Dr. Gilliland Occupational Study Thesis, Oct. 1992)

023 Schwarz Ex. 20 (3M Meeting Minutes with JR Mitchell, April 1979)

024 Schwarz Ex. 21 (3M Memo re Recommendations of Hodge and Mitchel, April 1979)

025 Schwarz Ex. 22 (DuPont June 1979 Meeting re Fluorochemicals in Blood)

026 Schwarz Ex. 23 (DuPont Memo on Fluorine Blood Levels, July 30 1979)

027 Schwarz Ex. 24 (3M Phone conversation with DuPont, July 26 1979)

028 Schwarz Ex. 25 (DuPont Organic Fluorides in Blood Analysis, Oct. 1 1979)

029 Schwarz Ex. 26 (DuPont C-8 Communications Meeting, July 31 1980)

030 Schwarz Ex. 27 (3M Teratology Studies in Rats)

031 Schwarz Ex. 28 (DuPont Recommendation re Fluorochemical Exposure to Females)

032 Schwarz Ex. 29 (DuPont Employee Communication re C-8)

033 Schwarz Ex. 30 (DuPont May 14 1981 C-8 Blood Sampling Memo)

034 Schwarz Ex. 31 (3M Letter to Office of Toxic Substances, Nov. 19 1980)

035 Schwarz Ex. 32 (C-8 (FC-143) Chronology)

036 Schwarz Ex. 33 (3M Roach Memo re Chemolite Health Evaluations, 1981)

037 Schwarz Ex. 34 (DuPont Toxicology of Perfluorooctanoate, Kennedy et al)

038 Schwarz Ex. 35 (3M Roach Memo re Organic Fluoriine Level, Aug. 31 1984)

039 Schwarz Ex. 36 (June 1984 DuPont Presentation re C-8 in Off-Plant Water Systems)

040 Schwarz Ex. 37 (August 1984 DuPont Summary of C-8 in Water Sampling Program

041 Schwarz Ex. 38 (DuPont Report re C-8 Reduction and Control Status, June 11 1987)

042 Schwarz Ex. 39 (Pastenbach Article on Washington Works Fate and Transport, 2007)

043 Schwarz Ex. 40 (3M FC-129 Biodegradability Memo, Dec. 30 1998)

044 Schwarz Ex. 41 (3M Memo re Organic Fluorine Meeting Notes, Dec. 4 1989)

045 Schwarz Ex. 42 (DuPont C-8 Review Meeting Agenda, April 26 1990)

046 Schwarz Ex. 43 (Abstract, Gilliland, Mortality Among Employees of a PFOA Prod. Plant)

047 Schwarz Ex. 44 (DuPont Memo re C-8 as a Potential Carcinogen)

048 Schwarz Ex. 45 (Minutes of APME Tox. Working Group, Dec 7 1994)

049 Schwarz Ex. 46 (DuPont Notes from APME Mtg, Oct. 12 1995)

050 Schwarz Ex. 47 (3M emails re Sharing APFO primate information, May 4 1999)

051 Schwarz Ex. 48 (DuPont C-8 Project Phase I Review, Jan. 27 1997)

052 Schwarz Ex. 49 (DuPont Internal email re monkey study, Sept 9 2008)

053 Schwarz Ex. 50 (Baker v. Sorin Grp. (M.D. Pa. 2017) – Medical Monitoring Decision)

054 Schwarz Ex. 51 (DuPont C-8 Pace Team Minutes, Sept 30 1998)

055 Schwarz Ex. 52 (DuPont C-8 Project Phase IIc Review, July 30 1998)

056 Schwarz Ex. 53 (DuPont C-8 Pace Team Minutes, Aug. 31 1998)

057 Schwarz Ex. 54 (DuPont Customer Presentation – Surfactant Changes)

058 Schwarz Ex. 55 (EPA Map of Hoosick Falls with well results, Aug. 2016)

059 Schwarz Ex. 56 (DuPont C-8 Pace Team Mtg. Notes & Charts, Oct. 1998)

060 Schwarz Ex. 57 (DuPont McCord to Cavanaugh email chain, Oct 25 1999)

061 Schwarz Ex. 58 (DuPont Cavanaugh to McCord email, Jan. 21, 2000)

062 Schwarz Ex. 59 (DuPont C8 Strategy Review Power Point, March 3 2000)

063 Schwarz Ex. 60 (Saint Gobain Canning to Crowe re Update on PFOA Situation, July 2006)

064 Schwarz Ex. 61 (DuPont Materials in Lieu of May 7 1998 PAC Mtg.)

065 Schwarz Ex. 62 (3M Occurrence of PFOA in Wildlife, Purdy, Oct. 16 1998)

066 Schwarz Ex. 63 (3M Buttenhoff confidential toxicology memo on PFOS)

067 Schwarz Ex. 64 (3M Purdy Email re Risk to Environment of PFOS, Dec. 3 1998)

068 Schwarz Ex. 65 (3M Purdy Resignation Email and Letter, Mar. 28 1999)

069 Schwarz Ex. 66 (Mtg. Notes Canning (StG) and Millet (3M), April 25 2006)

070 Schwarz Ex. 67 (3M Answers to Plaintiffs First Interrogatories)

071 Schwarz Ex. 68 (DuPont emails re C-8 Human Risk Assessment, Sept 14 1999)

072 Schwarz Ex. 71 (DuPont emails, April 5 2001)

073 Schwarz Ex. 72 (Saint Gobain R & D Powerpoint Review, April 29 2003)

074 Schwarz Ex. 73 (Selected pages from Rich Hoeck Deposition, Sept 19 2019)

075 Schwarz Ex. 74 (DuPont press release refuting health claims about PFOA)

076 Schwarz Ex. 75 (June 23, 2000 Letter from DuPonts Kennedy to EPA)

077 Schwarz Ex. 76 (Barr Dispersion Processor Material Balance Report, Feb. 2005)

078 Schwarz Ex. 77 (DuPont emails re Chemfab Confidentiality Agmt, Aug 30 2000)

079 Schwarz Ex. 78 (DuPont emails July 27 2001)

080 Schwarz Ex. 79 (2006 3M-EPA Consent Decree)

081 Schwarz Ex. 80 (Selected pages from Kristin Miller Dep., August 2019)

082 Schwarz Ex. 81 (Agmt and Plan of Reorganization Btwn Oak and Dodge Industries, 1967)

083 Schwarz Ex. 82 (Bargain and Sale Deed – Allied Signal to Furon, Feb. 2 1996)

084 Schwarz Ex. 83 (Acquisition Agmt Btwn Allied Signal and Oak Industries, Feb. 14 1986)

085 Schwarz Ex. 84 (Honeywell Responses to NYS Senate Interrogatories, Sept 2016)

085 Schwarz Ex. 85 (Selected pages of Honeywell Rule 30(b)(6) Dep., Nov. 6 2018)

086 Schwarz Ex. 86 (AlliedSignal Laminate Systems Inc. Certificate of Incorporation)

087 Schwarz Ex. 87 (Asset Purchase Agmt Btwn Furon Co. and AlliedSignal Laminate Systems)

088 Schwarz Ex. 88 (Saint Gobain Rule 30(b)(6) Depo. Exhibit re Corporate Structure)

089 Schwarz Ex. 89 (Allied Signal-DuPont Purchase Memo)

090 Schwarz Ex. 90 (Consignment Agmt – Allied Signal and DuPont)

091 Schwarz Ex. 91 (Furon emails re Dispersion Usage)

092 Schwarz Ex. 92 (Selected pages from Phil Guy Dep., Feb. 2019)

093 Schwarz Ex. 93 (Selected pages from William Noonan Dep., July 2019)

094 Schwarz Ex. 94 (Spreadsheet of Aqueous Dispersion Purchases 1997-2003)

095 Schwarz Ex. 96 (Invoice for sale of surfactants to Fluorglas, Dec. 1989)

096 Schwarz Ex. 97 (Spreadsheet of FC-143 and Dyneon Aqueous Dispersion Sales to Hoosick)

097 Schwarz Ex. 98 (Saint Gobain email re Fluoropolymer Purchases, Dec. 1 2015)

098 Schwarz Ex. 99 (IR Fabric Coating Oven Diagram – Hassel)

099 Schwarz Ex. 100 (Fluorglas FC-143 Mixing Procedure, Feb. 5 1988)

100 Schwarz Ex. 101 (Saint Gobain emails re use of FC-143)

101 Schwarz Ex. 102 (Selected pages of P.J. Beaumont Dep., May 2019)

102 Schwarz Ex. 103 (Allied Signal Permit Application to NYSDEC)

103 Schwarz Ex. 104 (Furon Opacity Emissions Study Report)

104 Schwarz Ex. 105 (Selected pages of Ed Canning Dep., July 2019)

105 Schwarz Ex. 106 (Adirondack 1997 Stack Testing)

106 Schwarz Ex. 107 (Canning Letter to NHDES, 2005)

107 Schwarz Ex. 108 (NYSDEC Consent Order with Furon)

108 Schwarz Ex. 109 (Furon Emission Control Study Plan)

109 Schwarz Ex. 110 (Canning Letter to NYSDEC Oct. 18 2002)

110 Schwarz Ex. 111 (McCaffrey Street Sewer Camera Inspection)

111 Schwarz Ex. 112 (Parsons Report Phase I)

112 Schwarz Ex. 113 (Parsons Report Phase II)

113 Schwarz Ex. 114 (Allied Signal Memo on Rhodes Review, Nov. 22 1988)

114 Schwarz Ex. 115 (MSDS FC-143, Nov. 1986)

115 Schwarz Ex. 116 (MSDS FC-143, Aug. 1991)

116 Schwarz Ex. 117 (DuPont PTFE MSDS)

117 Schwarz Ex. 118 (Chemfab Memo re mtg with DuPont, Mar. 17 1995)

118 Schwarz Ex. 119 (Memo re Mtg with ICI, July 20 1999)

119 Schwarz Ex. 120 (Risk Assessment in the Workplace, McCaffrey Street, 2001)

120 Schwarz Ex. 121 (Saint-Gobain Tymor Email, July 2 2003)

121 Schwarz Ex. 122 (Saint-Gobain Statement on Tymor Mission, Mar. 10 2006)

122 Schwarz Ex. 123 (Saint Gobain emails, July 1 2003)

123 Schwarz Ex. 124 (Saint Gobain emails on PFOA risk messaging, Feb. 22 2006)

124 Schwarz Ex. 125 (Barr Engineering Rep. to Saint Gobain re Merrimack Testing, 2003)

125 Schwarz Ex. 126 (Powerpoint presentation to R. Caliari, Sept. 22 2004)

126 Schwarz Ex. 127 (Saint Gobain Kilrush Air Dispersion Modeling Report)

127 Schwarz Ex. 128 (Saint Gobain email re NHDES mtg to discuss APFO, Oct. 2004)

128 Schwarz Ex. 129 (Saint Gobain email re Fluoropolymer related issues, Sept 9 2004)

129 Schwarz Ex. 130 (Saint Gobain Statement on PFOA Found in Hoosick Falls, Dec. 2014)

130 Schwarz Ex. 131 (Selected pages of Michael Hickey Dep., Sept. 2018)

131 Schwarz Ex. 132 (EPA Statement on Hoosick Falls Water Contamination, Dec. 17 2015)

132 Declaration of James J Bilsborrrow in Support of Class Certification

133 Declaration of Plaintiff Michele Baker in Support of Class Certification

134 Declaration of Plaintiff Charles Carr in Support of Class Certification

135 Declaration of Plaintiff Angela Corbett in Support of Class Certification

136 Declaration of Plaintiff Pamela Forrest in Support of Class Certification

137 Declaration of Plaintiff Michael Hickey in Support of Class Certification

138 Declaration of Plaintiff Kathleen Main-Lingener in Support of Class Certification

139 Declaration of Plaintiff Kristin Miller in Support of Class Certification

140 Declaration of Plaintiff Jennifer Plouffe in Support of Class Certification

141 Declaration of Plaintiff Silvia Potter in Support of Class Certification

142 Declaration of Plaintiff Daniel Schuttig in Support of Class Certification

143 Declaration of Nicholas Cheremisinoff in Support of Class Certification

144 Declaration of Alan Ducatman in Support of Class Certification

145 Declaration of Edgar Gentle in Support of Class Certification

146 Declaration of Mark Huncik in Support of Class Certification

147 Declaration of David Savitz in Support of Class Certification

148 Declaration of Hyeong-Moo Shin in Support of Class Certification

149 Declaration of Donald Siegel in Support of Class Certification

150 Declaration of Jeffrey Zabel in Support of Class Certification